Reports of an Ebola case recorded yesterday at the Korle Bu Polyclinic in Accra turned out to be a false alarm.
When the Daily Graphic visited the polyclinic yesterday, it was operating normally, except that patient attendance was low.
A senior official of the polyclinic attributed the low attendance to
the absence of some of its doctors who were attending a training
programme.
That assertion was corroborated by a notice by management dated January
9, 2015 and posted on a noticeboard for the attention of clients of the
polyclinic, which is quoted below:
“Notice is hereby given that there will be limited number of doctors on
duty from Tuesday, January 13, 2015. This is to enable them undergo
continuous professional training”.
False alarm
A source at the Korle Bu Teaching Hospital also dismissed the reported Ebola case at the polyclinic as false alarm.
It explained that a patient who reported at the polyclinic on Tuesday was suspected to have contracted the deadly Ebola virus.
However, it noted, preliminary investigations ruled out Ebola .
The source said the patient was, subsequently, transferred to the KATH for treatment.
It assured the general public that the KATH had set up Ebola response teams “to help deal with any case that may be detected.”
The source said people could, therefore, visit the hospital without any fear.
Two potential Ebola vaccines have been approved for
front-line trials in West Africa. The vaccines, developed
by GlaxoSmithKline and Merck & Co, are expected to begin trails in
Liberia at the end of January and Sierra Leone and Guinea in February.
The Merck vaccine were temporarily halted in December due to joint pain, a side effect later termed tolerable by the W
Having completed trials in the US and Europe, the next stage involves around 40,000 people being given the vaccine, including some healthcare workers. In a speech on 9 January, Marie-Paule Kieny, assistant director general of the WHO, was bullish, saying that the medical armoury against the disease was rapidly filling up.
The first stage of the process will involve three groups of 9,000 being given the vaccines in Liberia, the worst affected country. According to data from the WHO, over 21,000 people have been infected with Ebola and 0ver 8,200 have died. Although the rate of contagion has slowed recently, the outbreak is still raging on.
The Merck vaccine were temporarily halted in December due to joint pain, a side effect later termed tolerable by the W
Having completed trials in the US and Europe, the next stage involves around 40,000 people being given the vaccine, including some healthcare workers. In a speech on 9 January, Marie-Paule Kieny, assistant director general of the WHO, was bullish, saying that the medical armoury against the disease was rapidly filling up.
at this time last year I would have said the cupboard was empty, dry, but now the cupboard is clearly filling up rapidlyShe said.
The first stage of the process will involve three groups of 9,000 being given the vaccines in Liberia, the worst affected country. According to data from the WHO, over 21,000 people have been infected with Ebola and 0ver 8,200 have died. Although the rate of contagion has slowed recently, the outbreak is still raging on.


